|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24 TWD | +6.19% |
|
+7.38% | +20.00% |
| Apr. 15 | Orient Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Orient Pharma Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 889.91 million compared to TWD 511.86 million a year ago. Net income was TWD 22.29 million compared to net loss of TWD 28.76 million a year ago.
Basic earnings per share from continuing operations was TWD 0.1 compared to basic loss per share from continuing operations of TWD 0.15 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +20.00% | 155M | |
| +26.47% | 661B | |
| +26.74% | 566B | |
| -6.33% | 352B | |
| +19.35% | 332B | |
| +4.23% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.04% | 145B |
ORIENT PHARMA CO., LTD. 
